
Sbisop 40mg Tablet SR
Marketer
Sygnus Biotech
Salt Composition
Isoxsuprine (40mg)
Overview Sbisop 40mg Tablet SR
Sbisop 40mg Extended-Release Tablets act as both a vasodilator and a uterine relaxant. They're indicated for managing preterm labor (uterine contractions commencing before the expected delivery date) and treating peripheral vascular disorders. Sbisop 40mg ER Tablets may be ingested with or without food, but consistent timing maximizes efficacy. Always adhere to your physician's prescribed dosage and frequency, tailored to your specific condition. The optimal dosage is determined by your doctor to alleviate symptoms effectively. Swallow tablets whole with water. Continue treatment for the duration specified by your doctor. Lightheadedness is a prevalent side effect. Report any concerning or persistent symptoms to your physician. To mitigate dizziness, stand up gradually from a seated or recumbent position and refrain from operating vehicles or engaging in tasks requiring focused attention. Prior to commencing treatment, inform your doctor of any history of cardiovascular disease or bleeding disorders. Disclose all other medications you are currently using, as interactions may reduce Sbisop's effectiveness or alter its action. To minimize the risk of preterm labor, strenuous or stressful activities should be avoided.
Uses of Sbisop 40mg Tablet SR
Managing peripheral circulatory disorders | Intervention in preterm childbirth
Major Benefits of Sbisop 40mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 40mg Sbisop SR tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
Common Side effects of Sbisop 40mg Tablet SR:
- Dizziness
- Palpitations
- Vomiting
- Nausea
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Weakness
- Decreased blood pressure
How to use Sbisop 40mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 40mg Sbisop SR tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Sbisop 40mg Tablet SR works:
Sbisop 40mg Extended-Release Tablets contain a beta-adrenergic agonist that inhibits uterine smooth muscle contractions, thereby suppressing premature labor. This medication also vasodilates, enhancing blood flow and improving circulation to extremities (including hands, feet, and brain), offering therapeutic benefit in cases of peripheral vascular disease.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Sbisop 40mg Tablet SR is not established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Sbisop 40mg sustained-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Sbisop 40mg extended-release tablets with breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Sbisop 40mg Extended-Release Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the use of Sbisop 40mg sustained-release tablets in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Sbisop 40mg sustained-release tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Sbisop 40mg Tablet SR :
Should you forget to take a Sbisop 40mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid doubling the prescribed dosage.
Facts to Know About Sbisop 40mg Tablet SR
| Label | Value |
|---|---|
| Chemical Type | Phenylpropanoid |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
